nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—Etoposide—uterine cancer	0.16	0.542	CbGbCtD
Desmopressin—PTGS1—Etoposide—uterine cancer	0.135	0.458	CbGbCtD
Desmopressin—AVPR2—renal system—uterine cancer	0.00937	0.158	CbGeAlD
Desmopressin—PTGS1—oviduct—uterine cancer	0.00733	0.124	CbGeAlD
Desmopressin—PTGS1—artery—uterine cancer	0.00485	0.0818	CbGeAlD
Desmopressin—PTGS2—artery—uterine cancer	0.00464	0.0782	CbGeAlD
Desmopressin—PTGS2—myometrium—uterine cancer	0.00224	0.0378	CbGeAlD
Desmopressin—PTGS1—epithelium—uterine cancer	0.00184	0.031	CbGeAlD
Desmopressin—PTGS1—uterine cervix—uterine cancer	0.00182	0.0308	CbGeAlD
Desmopressin—PTGS1—smooth muscle tissue—uterine cancer	0.00177	0.0299	CbGeAlD
Desmopressin—PTGS2—epithelium—uterine cancer	0.00176	0.0297	CbGeAlD
Desmopressin—PTGS2—uterine cervix—uterine cancer	0.00174	0.0294	CbGeAlD
Desmopressin—PTGS1—renal system—uterine cancer	0.00171	0.0288	CbGeAlD
Desmopressin—PTGS2—smooth muscle tissue—uterine cancer	0.0017	0.0286	CbGeAlD
Desmopressin—PTGS1—endometrium—uterine cancer	0.00165	0.0278	CbGeAlD
Desmopressin—PTGS2—renal system—uterine cancer	0.00163	0.0275	CbGeAlD
Desmopressin—PTGS1—mammalian vulva—uterine cancer	0.0016	0.0269	CbGeAlD
Desmopressin—PTGS2—endometrium—uterine cancer	0.00158	0.0266	CbGeAlD
Desmopressin—PTGS1—uterus—uterine cancer	0.00152	0.0256	CbGeAlD
Desmopressin—PTGS2—uterus—uterine cancer	0.00145	0.0245	CbGeAlD
Desmopressin—PTGS1—female reproductive system—uterine cancer	0.00137	0.0231	CbGeAlD
Desmopressin—PTGS2—female reproductive system—uterine cancer	0.00131	0.022	CbGeAlD
Desmopressin—PTGS1—female gonad—uterine cancer	0.00124	0.021	CbGeAlD
Desmopressin—PTGS1—vagina—uterine cancer	0.00124	0.0208	CbGeAlD
Desmopressin—PTGS2—female gonad—uterine cancer	0.00119	0.0201	CbGeAlD
Desmopressin—PTGS2—vagina—uterine cancer	0.00118	0.0199	CbGeAlD
Desmopressin—Flushing—Etoposide—uterine cancer	0.00106	0.00174	CcSEcCtD
Desmopressin—Cardiac disorder—Etoposide—uterine cancer	0.00106	0.00174	CcSEcCtD
Desmopressin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00173	CcSEcCtD
Desmopressin—Dizziness—Progesterone—uterine cancer	0.00105	0.00172	CcSEcCtD
Desmopressin—Angiopathy—Etoposide—uterine cancer	0.00103	0.0017	CcSEcCtD
Desmopressin—Immune system disorder—Etoposide—uterine cancer	0.00103	0.00169	CcSEcCtD
Desmopressin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00169	CcSEcCtD
Desmopressin—Mediastinal disorder—Etoposide—uterine cancer	0.00103	0.00169	CcSEcCtD
Desmopressin—Chills—Etoposide—uterine cancer	0.00102	0.00168	CcSEcCtD
Desmopressin—Mental disability—Doxorubicin—uterine cancer	0.00102	0.00168	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00102	0.00167	CcSEcCtD
Desmopressin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00167	CcSEcCtD
Desmopressin—Vomiting—Progesterone—uterine cancer	0.00101	0.00165	CcSEcCtD
Desmopressin—Rash—Progesterone—uterine cancer	0.000999	0.00164	CcSEcCtD
Desmopressin—Dermatitis—Progesterone—uterine cancer	0.000998	0.00164	CcSEcCtD
Desmopressin—Headache—Progesterone—uterine cancer	0.000992	0.00163	CcSEcCtD
Desmopressin—Increased appetite—Epirubicin—uterine cancer	0.000984	0.00161	CcSEcCtD
Desmopressin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000982	0.00161	CcSEcCtD
Desmopressin—Decreased appetite—Dactinomycin—uterine cancer	0.000973	0.0016	CcSEcCtD
Desmopressin—Fatigue—Dactinomycin—uterine cancer	0.000965	0.00158	CcSEcCtD
Desmopressin—Pain—Dactinomycin—uterine cancer	0.000958	0.00157	CcSEcCtD
Desmopressin—Muscle spasms—Etoposide—uterine cancer	0.000955	0.00157	CcSEcCtD
Desmopressin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000949	0.00156	CcSEcCtD
Desmopressin—Nausea—Progesterone—uterine cancer	0.000941	0.00154	CcSEcCtD
Desmopressin—Hyponatraemia—Epirubicin—uterine cancer	0.000928	0.00152	CcSEcCtD
Desmopressin—Feeling abnormal—Dactinomycin—uterine cancer	0.000923	0.00151	CcSEcCtD
Desmopressin—Ill-defined disorder—Etoposide—uterine cancer	0.000921	0.00151	CcSEcCtD
Desmopressin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000916	0.0015	CcSEcCtD
Desmopressin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.0015	CcSEcCtD
Desmopressin—Increased appetite—Doxorubicin—uterine cancer	0.00091	0.00149	CcSEcCtD
Desmopressin—Affect lability—Epirubicin—uterine cancer	0.00091	0.00149	CcSEcCtD
Desmopressin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000905	0.00148	CcSEcCtD
Desmopressin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.00148	CcSEcCtD
Desmopressin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000899	0.00147	CcSEcCtD
Desmopressin—Malaise—Etoposide—uterine cancer	0.000895	0.00147	CcSEcCtD
Desmopressin—Vertigo—Etoposide—uterine cancer	0.000892	0.00146	CcSEcCtD
Desmopressin—Abdominal pain—Dactinomycin—uterine cancer	0.000885	0.00145	CcSEcCtD
Desmopressin—Body temperature increased—Dactinomycin—uterine cancer	0.000885	0.00145	CcSEcCtD
Desmopressin—Mood swings—Epirubicin—uterine cancer	0.000876	0.00144	CcSEcCtD
Desmopressin—Loss of consciousness—Etoposide—uterine cancer	0.000873	0.00143	CcSEcCtD
Desmopressin—Cough—Etoposide—uterine cancer	0.000866	0.00142	CcSEcCtD
Desmopressin—Convulsion—Etoposide—uterine cancer	0.00086	0.00141	CcSEcCtD
Desmopressin—Dehydration—Epirubicin—uterine cancer	0.00086	0.00141	CcSEcCtD
Desmopressin—Hyponatraemia—Doxorubicin—uterine cancer	0.000859	0.00141	CcSEcCtD
Desmopressin—Hypertension—Etoposide—uterine cancer	0.000857	0.00141	CcSEcCtD
Desmopressin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000853	0.0014	CcSEcCtD
Desmopressin—Chest pain—Etoposide—uterine cancer	0.000845	0.00139	CcSEcCtD
Desmopressin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000844	0.00138	CcSEcCtD
Desmopressin—Affect lability—Doxorubicin—uterine cancer	0.000842	0.00138	CcSEcCtD
Desmopressin—Hypokalaemia—Epirubicin—uterine cancer	0.000841	0.00138	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00084	0.00138	CcSEcCtD
Desmopressin—Discomfort—Etoposide—uterine cancer	0.000835	0.00137	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000832	0.00136	CcSEcCtD
Desmopressin—Hypersensitivity—Dactinomycin—uterine cancer	0.000825	0.00135	CcSEcCtD
Desmopressin—Confusional state—Etoposide—uterine cancer	0.000817	0.00134	CcSEcCtD
Desmopressin—Anaphylactic shock—Etoposide—uterine cancer	0.00081	0.00133	CcSEcCtD
Desmopressin—Mood swings—Doxorubicin—uterine cancer	0.00081	0.00133	CcSEcCtD
Desmopressin—Infection—Etoposide—uterine cancer	0.000805	0.00132	CcSEcCtD
Desmopressin—Abdominal distension—Epirubicin—uterine cancer	0.000804	0.00132	CcSEcCtD
Desmopressin—Asthenia—Dactinomycin—uterine cancer	0.000803	0.00132	CcSEcCtD
Desmopressin—PTGS1—lymph node—uterine cancer	0.0008	0.0135	CbGeAlD
Desmopressin—Influenza—Epirubicin—uterine cancer	0.000799	0.00131	CcSEcCtD
Desmopressin—Dehydration—Doxorubicin—uterine cancer	0.000795	0.0013	CcSEcCtD
Desmopressin—Tachycardia—Etoposide—uterine cancer	0.000791	0.0013	CcSEcCtD
Desmopressin—Skin disorder—Etoposide—uterine cancer	0.000787	0.00129	CcSEcCtD
Desmopressin—Hyperhidrosis—Etoposide—uterine cancer	0.000783	0.00128	CcSEcCtD
Desmopressin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000781	0.00128	CcSEcCtD
Desmopressin—Hypokalaemia—Doxorubicin—uterine cancer	0.000778	0.00128	CcSEcCtD
Desmopressin—Anorexia—Etoposide—uterine cancer	0.000772	0.00127	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00077	0.00126	CcSEcCtD
Desmopressin—Diarrhoea—Dactinomycin—uterine cancer	0.000766	0.00126	CcSEcCtD
Desmopressin—PTGS2—lymph node—uterine cancer	0.000765	0.0129	CbGeAlD
Desmopressin—Abdominal distension—Doxorubicin—uterine cancer	0.000744	0.00122	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000742	0.00122	CcSEcCtD
Desmopressin—Influenza—Doxorubicin—uterine cancer	0.000739	0.00121	CcSEcCtD
Desmopressin—Paraesthesia—Etoposide—uterine cancer	0.000728	0.00119	CcSEcCtD
Desmopressin—Weight increased—Epirubicin—uterine cancer	0.000727	0.00119	CcSEcCtD
Desmopressin—Dyspnoea—Etoposide—uterine cancer	0.000722	0.00118	CcSEcCtD
Desmopressin—Somnolence—Etoposide—uterine cancer	0.00072	0.00118	CcSEcCtD
Desmopressin—Vomiting—Dactinomycin—uterine cancer	0.000712	0.00117	CcSEcCtD
Desmopressin—Rash—Dactinomycin—uterine cancer	0.000706	0.00116	CcSEcCtD
Desmopressin—Decreased appetite—Etoposide—uterine cancer	0.000704	0.00116	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Etoposide—uterine cancer	0.0007	0.00115	CcSEcCtD
Desmopressin—Fatigue—Etoposide—uterine cancer	0.000699	0.00115	CcSEcCtD
Desmopressin—Constipation—Etoposide—uterine cancer	0.000693	0.00114	CcSEcCtD
Desmopressin—Pain—Etoposide—uterine cancer	0.000693	0.00114	CcSEcCtD
Desmopressin—Conjunctivitis—Epirubicin—uterine cancer	0.000692	0.00114	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000687	0.00113	CcSEcCtD
Desmopressin—Sweating—Epirubicin—uterine cancer	0.000683	0.00112	CcSEcCtD
Desmopressin—Weight increased—Doxorubicin—uterine cancer	0.000673	0.0011	CcSEcCtD
Desmopressin—Epistaxis—Epirubicin—uterine cancer	0.000672	0.0011	CcSEcCtD
Desmopressin—Feeling abnormal—Etoposide—uterine cancer	0.000668	0.0011	CcSEcCtD
Desmopressin—Nausea—Dactinomycin—uterine cancer	0.000665	0.00109	CcSEcCtD
Desmopressin—Gastrointestinal pain—Etoposide—uterine cancer	0.000663	0.00109	CcSEcCtD
Desmopressin—Urticaria—Etoposide—uterine cancer	0.000644	0.00106	CcSEcCtD
Desmopressin—Rhinitis—Epirubicin—uterine cancer	0.000641	0.00105	CcSEcCtD
Desmopressin—Abdominal pain—Etoposide—uterine cancer	0.000641	0.00105	CcSEcCtD
Desmopressin—Body temperature increased—Etoposide—uterine cancer	0.000641	0.00105	CcSEcCtD
Desmopressin—Conjunctivitis—Doxorubicin—uterine cancer	0.000641	0.00105	CcSEcCtD
Desmopressin—Sweating—Doxorubicin—uterine cancer	0.000632	0.00104	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—uterine cancer	0.000631	0.00104	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—uterine cancer	0.00063	0.00103	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—uterine cancer	0.000628	0.00103	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—uterine cancer	0.000627	0.00103	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—uterine cancer	0.000622	0.00102	CcSEcCtD
Desmopressin—Visual impairment—Epirubicin—uterine cancer	0.000616	0.00101	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—uterine cancer	0.000598	0.00098	CcSEcCtD
Desmopressin—Hypersensitivity—Etoposide—uterine cancer	0.000597	0.000979	CcSEcCtD
Desmopressin—Flushing—Epirubicin—uterine cancer	0.000593	0.000973	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—uterine cancer	0.000593	0.000973	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—uterine cancer	0.000593	0.000973	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000584	0.000958	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—uterine cancer	0.000583	0.000956	CcSEcCtD
Desmopressin—Asthenia—Etoposide—uterine cancer	0.000581	0.000953	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000581	0.000953	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—uterine cancer	0.00058	0.000951	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—uterine cancer	0.00058	0.000951	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—uterine cancer	0.000578	0.000947	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—uterine cancer	0.000576	0.000945	CcSEcCtD
Desmopressin—Chills—Epirubicin—uterine cancer	0.000574	0.000941	CcSEcCtD
Desmopressin—Pruritus—Etoposide—uterine cancer	0.000573	0.00094	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—uterine cancer	0.00057	0.000935	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—uterine cancer	0.00056	0.000919	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—uterine cancer	0.000557	0.000913	CcSEcCtD
Desmopressin—Erythema—Epirubicin—uterine cancer	0.000557	0.000913	CcSEcCtD
Desmopressin—Diarrhoea—Etoposide—uterine cancer	0.000554	0.000909	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—uterine cancer	0.000553	0.000907	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—uterine cancer	0.000549	0.0009	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—uterine cancer	0.000549	0.0009	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—uterine cancer	0.000548	0.000899	CcSEcCtD
Desmopressin—Tension—Epirubicin—uterine cancer	0.000546	0.000896	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—uterine cancer	0.000541	0.000887	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—uterine cancer	0.000537	0.00088	CcSEcCtD
Desmopressin—Dizziness—Etoposide—uterine cancer	0.000536	0.000879	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—uterine cancer	0.000535	0.000878	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—uterine cancer	0.000534	0.000876	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000533	0.000874	CcSEcCtD
Desmopressin—Chills—Doxorubicin—uterine cancer	0.000531	0.000871	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—uterine cancer	0.000518	0.00085	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—uterine cancer	0.000516	0.000847	CcSEcCtD
Desmopressin—Vomiting—Etoposide—uterine cancer	0.000515	0.000845	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—uterine cancer	0.000515	0.000845	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—uterine cancer	0.000515	0.000845	CcSEcCtD
Desmopressin—Agitation—Epirubicin—uterine cancer	0.000512	0.000839	CcSEcCtD
Desmopressin—Rash—Etoposide—uterine cancer	0.000511	0.000838	CcSEcCtD
Desmopressin—Dermatitis—Etoposide—uterine cancer	0.00051	0.000837	CcSEcCtD
Desmopressin—Headache—Etoposide—uterine cancer	0.000508	0.000833	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—uterine cancer	0.000507	0.000832	CcSEcCtD
Desmopressin—Tension—Doxorubicin—uterine cancer	0.000505	0.000829	CcSEcCtD
Desmopressin—Malaise—Epirubicin—uterine cancer	0.000502	0.000823	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—uterine cancer	0.0005	0.00082	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—uterine cancer	0.0005	0.00082	CcSEcCtD
Desmopressin—Syncope—Epirubicin—uterine cancer	0.000499	0.000819	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—uterine cancer	0.000495	0.000812	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—uterine cancer	0.000492	0.000807	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—uterine cancer	0.000489	0.000802	CcSEcCtD
Desmopressin—Cough—Epirubicin—uterine cancer	0.000486	0.000796	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—uterine cancer	0.000482	0.000791	CcSEcCtD
Desmopressin—Nausea—Etoposide—uterine cancer	0.000481	0.000789	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—uterine cancer	0.000481	0.000788	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000478	0.000784	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—uterine cancer	0.000474	0.000777	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—uterine cancer	0.000474	0.000777	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—uterine cancer	0.000473	0.000776	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—uterine cancer	0.000472	0.000774	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000471	0.000772	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—uterine cancer	0.000468	0.000768	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—uterine cancer	0.000464	0.000762	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—uterine cancer	0.000463	0.000759	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—uterine cancer	0.000462	0.000757	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—uterine cancer	0.000458	0.000751	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—uterine cancer	0.000455	0.000746	CcSEcCtD
Desmopressin—Oedema—Epirubicin—uterine cancer	0.000454	0.000745	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—uterine cancer	0.000454	0.000745	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—uterine cancer	0.000453	0.000742	CcSEcCtD
Desmopressin—Infection—Epirubicin—uterine cancer	0.000451	0.00074	CcSEcCtD
Desmopressin—Cough—Doxorubicin—uterine cancer	0.000449	0.000737	CcSEcCtD
Desmopressin—Shock—Epirubicin—uterine cancer	0.000447	0.000733	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—uterine cancer	0.000446	0.000732	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—uterine cancer	0.000445	0.000731	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—uterine cancer	0.000445	0.000729	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—uterine cancer	0.000443	0.000727	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—uterine cancer	0.000441	0.000724	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—uterine cancer	0.000439	0.00072	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—uterine cancer	0.000438	0.000719	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—uterine cancer	0.000438	0.000719	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—uterine cancer	0.000437	0.000717	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000435	0.000714	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—uterine cancer	0.000433	0.00071	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—uterine cancer	0.000433	0.00071	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—uterine cancer	0.000424	0.000695	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—uterine cancer	0.00042	0.000689	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—uterine cancer	0.00042	0.000689	CcSEcCtD
Desmopressin—Infection—Doxorubicin—uterine cancer	0.000418	0.000685	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000414	0.000679	CcSEcCtD
Desmopressin—Shock—Doxorubicin—uterine cancer	0.000414	0.000678	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—uterine cancer	0.000412	0.000676	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—uterine cancer	0.000411	0.000674	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—uterine cancer	0.00041	0.000673	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—uterine cancer	0.000408	0.00067	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—uterine cancer	0.000408	0.000669	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000406	0.000666	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—uterine cancer	0.000405	0.000664	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—uterine cancer	0.000404	0.000662	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—uterine cancer	0.000401	0.000657	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—uterine cancer	0.0004	0.000656	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—uterine cancer	0.000395	0.000648	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000392	0.000643	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—uterine cancer	0.000392	0.000642	CcSEcCtD
Desmopressin—Constipation—Epirubicin—uterine cancer	0.000388	0.000637	CcSEcCtD
Desmopressin—Pain—Epirubicin—uterine cancer	0.000388	0.000637	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000383	0.000628	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—uterine cancer	0.00038	0.000623	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—uterine cancer	0.000377	0.000619	CcSEcCtD
Desmopressin—Dyspnoea—Doxorubicin—uterine cancer	0.000375	0.000615	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—uterine cancer	0.000374	0.000614	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—uterine cancer	0.000374	0.000613	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000371	0.000609	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—uterine cancer	0.00037	0.000607	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—uterine cancer	0.000365	0.000599	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000363	0.000595	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—uterine cancer	0.000362	0.000594	CcSEcCtD
Desmopressin—Urticaria—Epirubicin—uterine cancer	0.000361	0.000592	CcSEcCtD
Desmopressin—Pain—Doxorubicin—uterine cancer	0.000359	0.000589	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—uterine cancer	0.000359	0.000589	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—uterine cancer	0.000359	0.000589	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—uterine cancer	0.000359	0.000589	CcSEcCtD
Desmopressin—Feeling abnormal—Doxorubicin—uterine cancer	0.000346	0.000568	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000344	0.000564	CcSEcCtD
Desmopressin—Hypersensitivity—Epirubicin—uterine cancer	0.000335	0.000549	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—uterine cancer	0.000334	0.000548	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—uterine cancer	0.000332	0.000545	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—uterine cancer	0.000332	0.000545	CcSEcCtD
Desmopressin—Asthenia—Epirubicin—uterine cancer	0.000326	0.000534	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—uterine cancer	0.000321	0.000527	CcSEcCtD
Desmopressin—Diarrhoea—Epirubicin—uterine cancer	0.000311	0.00051	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—uterine cancer	0.00031	0.000508	CcSEcCtD
Desmopressin—Asthenia—Doxorubicin—uterine cancer	0.000302	0.000495	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—uterine cancer	0.0003	0.000493	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—uterine cancer	0.000297	0.000488	CcSEcCtD
Desmopressin—Vomiting—Epirubicin—uterine cancer	0.000289	0.000474	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—uterine cancer	0.000288	0.000472	CcSEcCtD
Desmopressin—Rash—Epirubicin—uterine cancer	0.000286	0.00047	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—uterine cancer	0.000286	0.000469	CcSEcCtD
Desmopressin—Headache—Epirubicin—uterine cancer	0.000285	0.000467	CcSEcCtD
Desmopressin—Dizziness—Doxorubicin—uterine cancer	0.000278	0.000456	CcSEcCtD
Desmopressin—Nausea—Epirubicin—uterine cancer	0.00027	0.000442	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—uterine cancer	0.000267	0.000438	CcSEcCtD
Desmopressin—Rash—Doxorubicin—uterine cancer	0.000265	0.000435	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—uterine cancer	0.000265	0.000434	CcSEcCtD
Desmopressin—Headache—Doxorubicin—uterine cancer	0.000263	0.000432	CcSEcCtD
Desmopressin—Nausea—Doxorubicin—uterine cancer	0.00025	0.000409	CcSEcCtD
Desmopressin—AVPR2—Peptide ligand-binding receptors—CXCL8—uterine cancer	0.000221	0.00628	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RNF43—uterine cancer	0.000217	0.00615	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000215	0.00612	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00021	0.00597	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—CCL2—uterine cancer	0.000208	0.00589	CbGpPWpGaD
Desmopressin—AVPR1B—G alpha (q) signalling events—PIK3CA—uterine cancer	0.000206	0.00586	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	0.000201	0.0057	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—INHBA—uterine cancer	0.000198	0.00563	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000189	0.00536	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000188	0.00532	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.000185	0.00524	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKR1B10—uterine cancer	0.000181	0.00515	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.00018	0.00512	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKR1B10—uterine cancer	0.00018	0.00511	CbGpPWpGaD
Desmopressin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.000179	0.00509	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKR1C1—uterine cancer	0.000178	0.00506	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000178	0.00505	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000175	0.00497	CbGpPWpGaD
Desmopressin—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000174	0.00495	CbGpPWpGaD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.000173	0.00491	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000171	0.00485	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000167	0.00474	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—CXCL8—uterine cancer	0.000164	0.00466	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.000162	0.00459	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000158	0.0045	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000152	0.00432	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000152	0.00432	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000151	0.00429	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RNF43—uterine cancer	0.00015	0.00426	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.00015	0.00426	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000149	0.00424	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RNF43—uterine cancer	0.000149	0.00423	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000148	0.00421	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000148	0.00421	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—CCL2—uterine cancer	0.000144	0.00408	CbGpPWpGaD
Desmopressin—AVPR1A—G alpha (q) signalling events—PIK3CA—uterine cancer	0.000143	0.00406	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CCL2—uterine cancer	0.000143	0.00405	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.000141	0.00401	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.00014	0.00398	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	0.000139	0.00395	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000139	0.00395	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—INHBA—uterine cancer	0.000137	0.0039	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKR1C3—uterine cancer	0.000137	0.0039	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—INHBA—uterine cancer	0.000136	0.00387	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PGR—uterine cancer	0.000134	0.0038	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	0.000128	0.00363	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—YWHAE—uterine cancer	0.000128	0.00362	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000128	0.00362	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000127	0.00361	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000126	0.00357	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKR1C1—uterine cancer	0.000124	0.00351	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKR1C1—uterine cancer	0.000123	0.00349	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—FBXW7—uterine cancer	0.000122	0.00348	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000121	0.00343	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000121	0.00343	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	0.000118	0.00336	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000114	0.00324	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—CXCL8—uterine cancer	0.000114	0.00323	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CXCL8—uterine cancer	0.000113	0.00321	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000112	0.00317	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000111	0.00316	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	0.00011	0.00312	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000108	0.00308	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—STK11—uterine cancer	0.000107	0.00304	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CCL2—uterine cancer	0.000106	0.00302	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SOCS3—uterine cancer	0.0001	0.00284	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	9.79e-05	0.00278	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CDKN2B—uterine cancer	9.59e-05	0.00272	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKR1C3—uterine cancer	9.52e-05	0.0027	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKR1C3—uterine cancer	9.45e-05	0.00268	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SRD5A2—uterine cancer	9.36e-05	0.00266	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NDUFB11—uterine cancer	9.36e-05	0.00266	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IGF1R—uterine cancer	9.31e-05	0.00264	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PGR—uterine cancer	9.28e-05	0.00263	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—CXCL8—uterine cancer	9.27e-05	0.00263	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PGR—uterine cancer	9.21e-05	0.00261	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	9.15e-05	0.0026	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.1e-05	0.00258	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.86e-05	0.00252	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—YWHAE—uterine cancer	8.85e-05	0.00251	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—YWHAE—uterine cancer	8.79e-05	0.00249	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SMAD3—uterine cancer	8.76e-05	0.00249	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	8.69e-05	0.00247	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.59e-05	0.00244	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	8.5e-05	0.00241	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	8.49e-05	0.00241	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FBXW7—uterine cancer	8.48e-05	0.00241	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FBXW7—uterine cancer	8.42e-05	0.00239	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CXCL8—uterine cancer	8.42e-05	0.00239	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—FGFR2—uterine cancer	8.35e-05	0.00237	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	7.88e-05	0.00224	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NDUFB11—uterine cancer	7.43e-05	0.00211	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SRD5A2—uterine cancer	7.43e-05	0.00211	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—STK11—uterine cancer	7.42e-05	0.00211	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—CCL2—uterine cancer	7.38e-05	0.0021	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—STK11—uterine cancer	7.36e-05	0.00209	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—CCL2—uterine cancer	7.33e-05	0.00208	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.22e-05	0.00205	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ESR1—uterine cancer	7.15e-05	0.00203	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SOCS3—uterine cancer	6.94e-05	0.00197	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKR1B10—uterine cancer	6.9e-05	0.00196	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SOCS3—uterine cancer	6.89e-05	0.00196	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.82e-05	0.00194	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKR1B1—uterine cancer	6.77e-05	0.00192	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—STAR—uterine cancer	6.77e-05	0.00192	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—NRAS—uterine cancer	6.75e-05	0.00192	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	6.7e-05	0.0019	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.69e-05	0.0019	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN2B—uterine cancer	6.65e-05	0.00189	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN2B—uterine cancer	6.6e-05	0.00187	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IGF1R—uterine cancer	6.46e-05	0.00183	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—CXCL8—uterine cancer	6.43e-05	0.00182	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IGF1R—uterine cancer	6.41e-05	0.00182	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—CXCL8—uterine cancer	6.38e-05	0.00181	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CCL2—uterine cancer	6.29e-05	0.00179	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.24e-05	0.00177	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SMAD3—uterine cancer	6.07e-05	0.00172	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SMAD3—uterine cancer	6.03e-05	0.00171	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—PIK3CA—uterine cancer	5.88e-05	0.00167	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—CXCL8—uterine cancer	5.84e-05	0.00166	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—KRAS—uterine cancer	5.81e-05	0.00165	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—CXCL8—uterine cancer	5.79e-05	0.00165	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FGFR2—uterine cancer	5.79e-05	0.00164	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.78e-05	0.00164	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FGFR2—uterine cancer	5.75e-05	0.00163	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RNF43—uterine cancer	5.72e-05	0.00162	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.46e-05	0.00155	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKR1B1—uterine cancer	5.37e-05	0.00153	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—STAR—uterine cancer	5.37e-05	0.00153	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PIK3CA—uterine cancer	5.34e-05	0.00152	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—uterine cancer	5.34e-05	0.00152	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.32e-05	0.00151	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—POLD1—uterine cancer	5.31e-05	0.00151	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.31e-05	0.00151	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ERBB2—uterine cancer	5.24e-05	0.00149	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.07e-05	0.00144	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CXCL8—uterine cancer	4.97e-05	0.00141	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKR1C1—uterine cancer	4.97e-05	0.00141	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ESR1—uterine cancer	4.95e-05	0.00141	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HRAS—uterine cancer	4.94e-05	0.0014	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ESR1—uterine cancer	4.92e-05	0.0014	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CDKN1B—uterine cancer	4.86e-05	0.00138	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—AKT1—uterine cancer	4.8e-05	0.00136	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.8e-05	0.00136	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKR1C1—uterine cancer	4.71e-05	0.00134	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—NRAS—uterine cancer	4.68e-05	0.00133	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—NRAS—uterine cancer	4.65e-05	0.00132	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CTNNB1—uterine cancer	4.59e-05	0.0013	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PTEN—uterine cancer	4.47e-05	0.00127	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—RRM2—uterine cancer	4.43e-05	0.00126	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—AKT1—uterine cancer	4.36e-05	0.00124	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCL2—uterine cancer	4.36e-05	0.00124	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCL2—uterine cancer	4.33e-05	0.00123	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—DCN—uterine cancer	4.3e-05	0.00122	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EP300—uterine cancer	4.27e-05	0.00121	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—POLD1—uterine cancer	4.22e-05	0.0012	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.08e-05	0.00116	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—PIK3CA—uterine cancer	4.08e-05	0.00116	CbGpPWpGaD
Desmopressin—PTGS2—Disease—DCN—uterine cancer	4.08e-05	0.00116	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP11A1—uterine cancer	4.05e-05	0.00115	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—PIK3CA—uterine cancer	4.05e-05	0.00115	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—VEGFA—uterine cancer	4.04e-05	0.00115	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—uterine cancer	4.03e-05	0.00114	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—uterine cancer	4e-05	0.00114	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NRAS—uterine cancer	3.99e-05	0.00113	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKR1C1—uterine cancer	3.94e-05	0.00112	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKR1C3—uterine cancer	3.83e-05	0.00109	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.75e-05	0.00107	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PIK3CA—uterine cancer	3.7e-05	0.00105	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PIK3CA—uterine cancer	3.68e-05	0.00104	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—uterine cancer	3.64e-05	0.00103	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.63e-05	0.00103	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKR1C3—uterine cancer	3.63e-05	0.00103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—uterine cancer	3.61e-05	0.00102	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HMGA1—uterine cancer	3.53e-05	0.001	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—RRM2—uterine cancer	3.52e-05	0.000998	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL8—uterine cancer	3.45e-05	0.000979	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—uterine cancer	3.43e-05	0.000975	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—uterine cancer	3.43e-05	0.000973	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL8—uterine cancer	3.42e-05	0.000972	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—DCN—uterine cancer	3.41e-05	0.000969	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—uterine cancer	3.4e-05	0.000966	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1B—uterine cancer	3.37e-05	0.000956	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1B—uterine cancer	3.34e-05	0.000949	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—uterine cancer	3.33e-05	0.000946	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—uterine cancer	3.31e-05	0.000939	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FBXW7—uterine cancer	3.23e-05	0.000918	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP11A1—uterine cancer	3.22e-05	0.000913	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CTNNB1—uterine cancer	3.18e-05	0.000903	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CTNNB1—uterine cancer	3.16e-05	0.000897	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PIK3CA—uterine cancer	3.16e-05	0.000896	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—uterine cancer	3.1e-05	0.00088	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—uterine cancer	3.08e-05	0.000874	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.07e-05	0.00087	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—uterine cancer	3.05e-05	0.000867	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKR1C3—uterine cancer	3.04e-05	0.000862	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—uterine cancer	3.02e-05	0.000859	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—uterine cancer	3e-05	0.000853	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—STK11—uterine cancer	2.98e-05	0.000846	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP19A1—uterine cancer	2.98e-05	0.000846	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EP300—uterine cancer	2.96e-05	0.000839	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EP300—uterine cancer	2.94e-05	0.000833	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—uterine cancer	2.92e-05	0.000829	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—VEGFA—uterine cancer	2.8e-05	0.000795	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.8e-05	0.000794	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—VEGFA—uterine cancer	2.78e-05	0.000789	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRAS—uterine cancer	2.77e-05	0.000785	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRAS—uterine cancer	2.75e-05	0.00078	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.67e-05	0.000758	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—uterine cancer	2.58e-05	0.000732	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN2B—uterine cancer	2.53e-05	0.000719	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—uterine cancer	2.38e-05	0.000676	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—STK11—uterine cancer	2.37e-05	0.000672	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP19A1—uterine cancer	2.37e-05	0.000672	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—uterine cancer	2.36e-05	0.000671	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SMAD3—uterine cancer	2.31e-05	0.000657	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTHFR—uterine cancer	2.24e-05	0.000636	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.22e-05	0.000631	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR2—uterine cancer	2.21e-05	0.000626	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CA—uterine cancer	2.19e-05	0.000621	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CA—uterine cancer	2.17e-05	0.000617	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTHFR—uterine cancer	2.12e-05	0.000603	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.12e-05	0.000601	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—uterine cancer	2.12e-05	0.000601	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—uterine cancer	2.1e-05	0.000596	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—uterine cancer	2.02e-05	0.000575	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—uterine cancer	2.01e-05	0.00057	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.97e-05	0.00056	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—uterine cancer	1.79e-05	0.000507	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTHFR—uterine cancer	1.78e-05	0.000505	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—uterine cancer	1.77e-05	0.000504	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.57e-05	0.000445	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—uterine cancer	1.38e-05	0.000393	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1B—uterine cancer	1.28e-05	0.000364	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—uterine cancer	1.25e-05	0.000354	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CTNNB1—uterine cancer	1.21e-05	0.000344	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—EP300—uterine cancer	1.19e-05	0.000337	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—uterine cancer	1.18e-05	0.000335	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EP300—uterine cancer	1.13e-05	0.00032	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRAS—uterine cancer	1.05e-05	0.000299	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—uterine cancer	9.89e-06	0.000281	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—EP300—uterine cancer	9.43e-06	0.000268	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—uterine cancer	9.07e-06	0.000258	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CA—uterine cancer	8.79e-06	0.00025	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CA—uterine cancer	8.33e-06	0.000237	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—uterine cancer	7.71e-06	0.000219	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—uterine cancer	7.18e-06	0.000204	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CA—uterine cancer	6.98e-06	0.000198	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—uterine cancer	6.81e-06	0.000193	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—uterine cancer	5.7e-06	0.000162	CbGpPWpGaD
